Haznedaroglu, I. C. MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML). Mediterr J Hematol Infect Dis 2013, 6, e2014009.